Clinical Trials List
Protocol NumberTAS-117-201
2022-08-22 - 2022-09-22
Phase II
Terminated1
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jeng-Shiun Du Division of Hematology & Oncology
- Chieh-Han Chuang Division of General Surgery
- Shang-Jyh Hwang Division of Endocrinology
- 高育青 Division of Hematology & Oncology
- Cheng-Yu Long Division of Obstetrics & Gynecology
- 白哲聲 Division of Endocrinology
- Hui-Ching Wang Division of Hematology & Oncology
- Shen Liang Shih Division of General Surgery
- Ching-Chia Li Division of Urology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Wen-Jeng Wu Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
100 participants
